DOCSLIB.ORG

Universal Reporting Form

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Universal Reporting Form New York City Department of Health and Mental Hygiene Universal Reporting Form To report an immediately notifiable disease or condition, an outbreak among three or more persons or an unusual manifestation of any disease or condition, or any newly apparent or emerging disease or syndrome, call the Provider Access Line at 866-692-3641. Diseases and conditions in green and marked with * are immediately notifable; those marked with † are immediately notifiable if case meets the risk group criteria on page 2. Report by calling 866-692-3641. For all other diseases and conditions, report using Reporting Central online via NYCMED at www.nyc.gov/health/nycmed, mail this form to the NYC Department of Health and Mental Hygiene, 42-09 28th Street, CN-22, Long Island City, NY 11101, or call 866-692-3641 for the appropriate fax number. Go to www.nyc.gov/health/diseasereporting for more information. Patient Information Patient Last Name First Name Middle Name DATE OF REPORT Patient AKA: Last Name AKA: First Name AKA: Middle Name _______ /_______ /_______ Age Date of Birth Country of Birth Social Security Number DATE OF DIAGNOSIS _______ /_______ /_______ If patient is a child, Guardian Last Name Guardian First Name Guardian Middle Name _______ /_______ /_______ Medical Record Number Medicaid Number DATE OF ILLNESS ONSET Patient Home Address City State Zip Code _______ /_______ /_______ Country Borough: M Manhattan M Bronx M Brooklyn M Queens M Staten Island M Unknown M Not NYC Email Address Mobile Phone Home Phone M Homeless Sex M Male M Transgender MTF Race M Black M American Indian/Alaska Native M Asian Ethnicity M Hispanic M Unknown M Female M Transgender FTM M Unknown M White M Native Hawaiian/Pacific Islander M Other: _____________________ M Unknown M Non-Hispanic Is patient alive? M Yes M No M Unknown Is patient pregnant? M Yes M No M Unknown Is case suspected to be due to healthcare associated transmission? If no, date of death: _______ /_______ /______ If yes, due date: _______ /_______ /_______ M Yes M No M Unknown Was patient admitted to hospital? M Yes M No M Unknown Is patient a newborn infant? M Yes M No M Unknown Admission date: _______ /_______ /_______ If yes, name of hospital where infant was born Discharge date: _______ /_______ /_______ Name of facility where infant’s mother obtained prenatal care Foreign travel Countries Date returned to U.S. _______ /_______ /_______ Other Information Name of Person Reporting Disease Email address Phone R TE Name of Facility of Person Reporting Disease National Provider Identifier (NPI) Code Permanent Facility Identifier (PFI) Code R REPO Facility Street Address City State Zip Code Name of Hospital/Healthcare Facility Providing Care for Patient Facility National Provider Identifier (NPI) Code Permanent Facility Identifier (PFI) Code ILITY C Facility Street Address City State Zip Code FA Name of Testing Laboratory Phone CLIA Number AB L Laboratory Street Address City State Zip Code Name of Provider Caring for Patient National Provider Identifier (NPI) Code Fax R E D Email address Phone Mobile OVI PR Provider Street Address City State Zip Code Form PD-16 (Rev. 3/2017) -1- Patient Last Name First Name Medical Record Number Diseases and conditions in green and marked with * are immediately notifable; those marked with † are immediately notifiable if case meets the risk group criteria at the bottom of the page. Report by calling 866-692-3641. For all other diseases and conditions, report using Reporting Central online via NYCMED at www.nyc.gov/health/nycmed, mail this form to the NYC Department of Health and Mental Hygiene, 42-09 28th Street, CN-22, Long Island City, NY 11101, or call 866-692-3641 for the appropriate fax number. Go to www.nyc.gov/health/diseasereporting for more information. Ricin poisoning M Amebiasis† M Haemophilus influenzae (invasive disease)† Influenza M * M Rickettsialpox M Anaplasmosis (Human granulocytic anaplasmosis) Test type: M Suspected novel viral strain with pandemic V Culture V Antigen M Rocky Mountain spotted fever Animal bite – see Environmental Conditions potential (e.g., avian H5N1 or H7N9)* PCR section on page 3. See rabies if potential for V V Gram stain M Death in a child aged 18 or younger M Rubella (German measles)* V Other ____________________ exposure. Lead poisoning – see Poisonings section on page 3 M Rubella syndrome, congenital † M Anthrax* Specimen Source: M Legionellosis† M Salmonellosis V Blood V CSF V Unknown Serogroup: ______________________ M Arboviral infections, acute* Specify positive test: If due to Salmonella typhi or paratyphi, ______________________ V Other ______________________ Specify which virus: V Culture V Urine antigen select Typhoid or Paratyphoid Fever. If Chikungunya, Dengue, West Nile, Yellow Fever or Specify Serotype: Zika report as such. V DFA V Serology M Severe or novel coronavirus (e.g., SARS or V Type B V Not typeable Attach copies of diagnostic laboratory results if V NAAT or PCR MERS-CoV)* V Not tested V Unknown available. M Leprosy (Hansen’s disease) M Shiga-toxin producing Escherichia coli (STEC) V Other ______________________ M Babesiosis M Leptospirosis infection† † M Botulism* M Hantavirus disease* M Listeriosis† M Shigellosis V Foodborne V Infant V Wound M Hemolytic uremic syndrome M Lyme disease M Smallpox (variola)* M Brucellosis* Erythema migrans present? M Staphylococcal enterotoxin B poisoning* M Campylobacteriosis† FOR ALL HEPATITIS REPORTS V Yes V No V Unknown M Staphylococcus aureus, vancomycin intermediate (VISA) and resistant (VRSA)* Carbon Monoxide poisoning* – see Poisonings Jaundice V Yes V No V Unknown M Lymphocytic choriomeningitis virus section on page 3 Lymphogranuloma venereum – see STD section Source: _________ ALT (SGPT) value:___________ V Unknown MIC (µg/ml): Chancroid – see STD section on page 4 on page 4 ______ Lab reference range:_________ V Unknown † † M Chikungunya M Malaria M Streptococcus (Group A and B) invasive Specify Source: Blood CSF Unknown Select at least one of the following: V V V – see STD section on page 4 M Hepatitis A† Chlamydia V Other, Specify:___________ Total Ab to Hepatitis A is NOT reportable. V falciparum V vivax V malariae M Cholera* IgM anti-HAV: V Pos V Neg V Unknown V ovale V undetermined Syphilis, including congenital – see STD section Creutzfeldt-Jakob disease – see Transmissable on page 4 M Hepatitis B† Complete Foreign Travel section on page 1. spongiform encephalopathy M Tetanus Report at least one positive hepatitis B test result. M Measles (rubeola)* M Cryptosporidiosis† Total Ab to Hepatitis B is not reportable. M Toxic shock syndrome M Melioidosis* M Cyclosporiasis† IgM anti-HBc: V Pos V Neg V Unknown M Trachoma M Meningitis, bacterial M Dengue HBsAg: V Pos V Neg V Unknown M Transmissible spongiform encephalopathy Specify bacteria identified _________________ Attach copies of dengue diagnostic laboratory HBeAg: V Pos V Neg V Unknown (Creutzfeldt-Jakob disease and variants) results if available. M Meningococcal disease, invasive (including Testing done: _________________ HBV Nucleic Acid: V Pos V Neg V Unknown (e.g. 14-3-3 on CSF, brain biopsy, autopsy, EEG/MRI) M Diphtheria* meningitis) * If IgM is positive, describe symptoms and risk in Test type/Specimen source: M Trichinosis Drownings – see Environmental Conditions comments box on last page. section on page 3 V Blood culture V CSF culture Tuberculosis – see Tuberculosis section on page 3 Hepatitis B in pregnancy V Antigen test from CSF V Gram stain M Tularemia* M Ehrlichiosis (Human monocytic ehrlichiosis) Report cases in Reporting Central or fax IMM-5 form If human granulocytic anaplasmosis report as to 347-396-2558. For more information, call V PCR V Other ____________________ M Typhoid fever† anaplasmosis. 347-396-2403. M Monkeypox* M Vaccinia disease (adverse events associated M Encephalitis M Hepatitis C† M Mumps† with smallpox vaccination)* If Jul.1–Oct. 31 consider and test for West Nile virus. Check all that apply: † M Paratyphoid fever M Vibrio species, non-cholera If due to another reportable disease (e.g. Lyme, West V EIA pos Nile, arbovirus), report under the other disease. M Pertussis (whooping cough)† Specify species:________________________ V HCV Nucleic Acid (e.g.PCR) pos M Escherichia coli O157:H7 infection† M Pesticide poisoning - see Poisonings section on M Viral hemorrhagic fever* Is this an acute infection? page 3 – see Environmental M West Nile fever and viral neuroinvasive disease Falls from windows V Yes (e.g., meningitis and encephalitis) Conditions section on page 3 M Plague* V No Attach copies of diagnostic laboratory results Poisoning – see Poisonings section on page 3 if available. M Food poisoning in a group of 2 or more V Unknown individuals* M Poliomyelitis* M Yellow fever* Herpes, neonatal – see STD section on page 4 M Giardiasis† M Psittacosis Attach copies of diagnostic laboratory results if available. M Glanders* HIV/AIDS M Q Fever* M Yersiniosis, non-plague† Gonorrhea – see STD section on page 4 Report using the New York State Provider Report M Rabies and exposure to rabies* – see animal Form (PRF). Call 518-474-4284 for forms or M Zika bites in Environmental Conditions section on page 3 Granuloma inguinale – see STD section on page 4 212-442-3388 for more information. *Report suspected and confirmed cases immediately to 1-866-692-3641 †If case meets any of the risk group criteria below, report immediately to 1-866-692-3641 Risk Groups for Disease Exposure/Transmission Complete this section for diseases marked with † and if case meets any criteria,
Load more

Recommended publications
  • Reporting of Diseases and Conditions Regulation, Amendment, M.R. 289/2014
    THE PUBLIC HEALTH ACT LOI SUR LA SANTÉ PUBLIQUE (C.C.S.M. c. P210) (c. P210 de la C.P.L.M.) Reporting of Diseases and Conditions Règlement modifiant le Règlement sur la Regulation, amendment déclaration de maladies et d'affections Regulation 289/2014 Règlement 289/2014 Registered December 23, 2014 Date d'enregistrement : le 23 décembre 2014 Manitoba Regulation 37/2009 amended Modification du R.M. 37/2009 1 The Reporting of Diseases and 1 Le présent règlement modifie le Conditions Regulation , Manitoba Règlement sur la déclaration de maladies et Regulation 37/2009, is amended by this d'affections , R.M. 37/2009. regulation. 2 Schedules A and B are replaced with 2 Les annexes A et B sont remplacées Schedules A and B to this regulation. par les annexes A et B du présent règlement. Coming into force Entrée en vigueur 3 This regulation comes into force on 3 Le présent règlement entre en vigueur January 1, 2015, or on the day it is registered le 1 er janvier 2015 ou à la date de son under The Statutes and Regulations Act , enregistrement en vertu de Loi sur les textes whichever is later. législatifs et réglementaires , si cette date est postérieure. December 19, 2014 Minister of Health/La ministre de la Santé, 19 décembre 2014 Sharon Blady 1 SCHEDULE A (Section 1) 1 The following diseases are diseases requiring contact notification in accordance with the disease-specific protocol. Common name Scientific or technical name of disease or its infectious agent Chancroid Haemophilus ducreyi Chlamydia Chlamydia trachomatis (including Lymphogranuloma venereum (LGV) serovars) Gonorrhea Neisseria gonorrhoeae HIV Human immunodeficiency virus Syphilis Treponema pallidum subspecies pallidum Tuberculosis Mycobacterium tuberculosis Mycobacterium africanum Mycobacterium canetti Mycobacterium caprae Mycobacterium microti Mycobacterium pinnipedii Mycobacterium bovis (excluding M.
    [Show full text]
  • Q Fever in Small Ruminants and Its Public Health Importance
    Journal of Dairy & Veterinary Sciences ISSN: 2573-2196 Review Article Dairy and Vet Sci J Volume 9 Issue 1 - January 2019 Copyright © All rights are reserved by Tolera Tagesu Tucho DOI: 10.19080/JDVS.2019.09.555752 Q Fever in Small Ruminants and its Public Health Importance Tolera Tagesu* School of Veterinary Medicine, Jimma University, Ethiopia Submission: December 01, 2018; Published: January 11, 2019 *Corresponding author: Tolera Tagesu Tucho, School of Veterinary Medicine, Jimma University, Jimma Oromia, Ethiopia Abstract Query fever is caused by Coxiella burnetii, it’s a worldwide zoonotic infectious disease where domestic small ruminants are the main reservoirs for human infections. Coxiella burnetii, is a Gram-negative obligate intracellular bacterium, adapted to thrive within the phagolysosome of the phagocyte. Humans become infected primarily by inhaling aerosols that are contaminated with C. burnetii. Ingestion (particularly drinking raw milk) and person-to-person transmission are minor routes. Animals shed the bacterium in urine and feces, and in very high concentrations in birth by-products. The bacterium persists in the environment in a resistant spore-like form which may become airborne and transported long distances by the wind. It is considered primarily as occupational disease of workers in close contact with farm animals or processing their be commenced immediately whenever Q fever is suspected. To prevent both the introduction and spread of Q fever infection, preventive measures shouldproducts, be however,implemented it may including occur also immunization in persons without with currently direct contact. available Doxycycline vaccines drugof domestic is the first small line ruminant of treatment animals for Q and fever.
    [Show full text]
  • Syphilis Staging and Treatment Syphilis Is a Sexually Transmitted Disease (STD) Caused by the Treponema Pallidum Bacterium
    Increasing Early Syphilis Cases in Illinois – Syphilis Staging and Treatment Syphilis is a sexually transmitted disease (STD) caused by the Treponema pallidum bacterium. Syphilis can be separated into four different stages: primary, secondary, early latent, and late latent. Ocular and neurologic involvement may occur during any stage of syphilis. During the incubation period (time from exposure to clinical onset) there are no signs or symptoms of syphilis, and the individual is not infectious. Incubation can last from 10 to 90 days with an average incubation period of 21 days. During this period, the serologic testing for syphilis will be non-reactive but known contacts to early syphilis (that have been exposed within the past 90 days) should be preventatively treated. Syphilis Stages Primary 710 (CDC DX Code) Patient is most infectious Chancre (sore) must be present. It is usually marked by the appearance of a single sore, but multiple sores are common. Chancre appears at the spot where syphilis entered the body and is usually firm, round, small, and painless. The chancre lasts three to six weeks and will heal without treatment. Without medical attention the infection progresses to the secondary stage. Secondary 720 Patient is infectious This stage typically begins with a skin rash and mucous membrane lesions. The rash may manifest as rough, red, or reddish brown spots on the palms of the hands, soles of the feet, and/or torso and extremities. The rash does usually does not cause itching. Rashes associated with secondary syphilis can appear as the chancre is healing or several weeks after the chancre has healed.
    [Show full text]
  • Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting As Cellulitis Kelly L
    Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed DO Lehigh Valley Health Network, [email protected] Nektarios I. Lountzis MD Lehigh Valley Health Network, [email protected] Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine Part of the Dermatology Commons, and the Medical Sciences Commons Published In/Presented At Reed, K., Lountzis, N. (2015, April 24). Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis. Poster presented at: Atlantic Dermatological Conference, Philadelphia, PA. This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator. For more information, please contact [email protected]. Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed, DO and Nektarios Lountzis, MD Lehigh Valley Health Network, Allentown, Pennsylvania Case Presentation: Discussion: Patient: 83 year-old Hispanic female Cutaneous tuberculosis (CTB) was first described in the literature in 1826 by Laennec and has since been History of Present Illness: The patient presented to the hospital for chest pain and shortness of breath and was treated for an NSTEMI. She was noted reported to manifest in a variety of clinical presentations. The most common cause is infection with the to have redness and swelling involving the right lower extremity she admitted to having for 5 months, which had not responded to multiple courses of antibiotics. She acid-fast bacillus Mycobacterium tuberculosis via either primary exogenous inoculation (direct implantation resided in Puerto Rico but recently moved to the area to be closer to her children.
    [Show full text]
  • Pdf/Bookshelf NBK368467.Pdf
    BMJ 2019;365:l4159 doi: 10.1136/bmj.l4159 (Published 28 June 2019) Page 1 of 11 Practice BMJ: first published as 10.1136/bmj.l4159 on 28 June 2019. Downloaded from PRACTICE CLINICAL UPDATES Syphilis OPEN ACCESS Patrick O'Byrne associate professor, nurse practitioner 1 2, Paul MacPherson infectious disease specialist 3 1School of Nursing, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada; 2Sexual Health Clinic, Ottawa Public Health, Ottawa, Ontario K1N 5P9; 3Division of Infectious Diseases, Ottawa Hospital General Campus, Ottawa, Ontario What you need to know Box 1: Symptoms of syphilis by stage of infection (see fig 1) • Incidence rates of syphilis have increased substantially around the Primary world, mostly affecting men who have sex with men and people infected • Symptoms appear 10-90 days (mean 21 days) after exposure with HIV http://www.bmj.com/ • Main symptom is a <2 cm chancre: • Have a high index of suspicion for syphilis in any sexually active patient – Progresses from a macule to papule to ulcer over 7 days with genital lesions or rashes – Painless, solitary, indurated, clean base (98% specific, 31% sensitive) • Primary syphilis classically presents as a single, painless, indurated genital ulcer (chancre), but this presentation is only 31% sensitive; – On glans, corona, labia, fourchette, or perineum lesions can be painful, multiple, and extra-genital – A third are extragenital in men who have sex with men and in women • Diagnosis is usually based on serology, using a combination of treponemal and non-treponemal tests. Syphilis remains sensitive to • Localised painless adenopathy benzathine penicillin G Secondary on 24 September 2021 by guest.
    [Show full text]
  • Healthcare Providers* Report Immediately by Phone!
    Effective July 2008 COMMUNICABLE AND OTHER INFECTIOUS DISEASES REPORTABLE IN MASSACHUSETTS BY HEALTHCARE PROVIDERS* *The list of reportable diseases is not limited to those designated below and includes only those which are primarily reportable by clinical providers. A full list of reportable diseases in Massachusetts is detailed in 105 CMR 300.100. REPORT IMMEDIATELY BY PHONE! This includes both suspect and confirmed cases. All cases should be reported to your local board of health; if unavailable, call the Massachusetts Department of Public Health: Telephone: (617) 983-6800 Confidential Fax: (617) 983-6813 • REPORT PROMPTLY (WITHIN 1-2 BUSINESS DAYS). This includes both suspect and confirmed cases. All cases should be reported to your local board of health; if unavailable, call the Massachusetts Department of Public Health: Telephone: (617) 983-6800 Confidential Fax: (617) 983-6813 • Anaplasmosis • Leptospirosis Anthrax • Lyme disease Any case of an unusual illness thought to have Measles public health implications • Melioidosis Any cluster/outbreak of illness, including but not Meningitis, bacterial, community acquired limited to foodborne illness • Meningitis, viral (aseptic), and other infectious Botulism (non-bacterial) Brucellosis Meningococcal disease, invasive • Chagas disease (Neisseria meningitidis) • Creutzfeldt-Jakob disease (CJD) and variant CJD Monkeypox or other orthopox virus Diphtheria • Mumps • Ehrlichiosis • Pertussis • Encephalitis, any cause Plague • Food poisoning and toxicity (includes poisoning
    [Show full text]
  • Nonbacterial Pus-Forming Diseases of the Skin Robert Jackson,* M.D., F.R.C.P[C], Ottawa, Ont
    Nonbacterial pus-forming diseases of the skin Robert Jackson,* m.d., f.r.c.p[c], Ottawa, Ont. Summary: The formation of pus as a Things are not always what they seem Fungus result of an inflammatory response Phaedrus to a bacterial infection is well known. North American blastomycosis, so- Not so well appreciated, however, The purpose of this article is to clarify called deep mycosis, can present with a is the fact that many other nonbacterial the clinical significance of the forma¬ verrucous proliferating and papilloma- agents such as certain fungi, viruses tion of pus in various skin diseases. tous plaque in which can be seen, par- and parasites may provoke pus Usually the presence of pus in or on formation in the skin. Also heat, the skin indicates a bacterial infection. Table I.Causes of nonbacterial topical applications, systemically However, by no means is this always pus-forming skin diseases administered drugs and some injected true. From a diagnostic and therapeutic Fungus materials can do likewise. Numerous point of view it is important that physi¬ skin diseases of unknown etiology cians be aware of the nonbacterial such as pustular acne vulgaris, causes of pus-forming skin diseases. North American blastomycosis pustular psoriasis and pustular A few definitions are required. Pus dermatitis herpetiformis can have is a yellowish [green]-white, opaque, lymphangitic sporotrichosis bacteriologically sterile pustules. The somewhat viscid matter (S.O.E.D.). Pus- cervicofacial actinomycosis importance of considering nonbacterial forming diseases are those in which Intermediate causes of pus-forming conditions of pus can be seen macroscopicaily.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Bioterrorism Diseases Annex Infectious Disease Emergency Response (IDER) Plan
    Bioterrorism Diseases Annex Infectious Disease Emergency Response (IDER) Plan Contents I Background IV Activation & Notification II Response Organization V Operational Guidance III Purpose & Objectives VI Resources I. BACKGROUND A bioterrorism event is defined for the purposes of this annex as the deliberate introduction of pathogenic microorganisms or their products (bacteria, viruses, fungi or toxins) into a community. Potential bioterrorism agents are categorized by the Centers for Disease Control and Prevention (CDC) by category. Category A agents (highest priority) include organisms that pose a risk to national security because they can be easily disseminated or transmitted from person-to-person; result in high mortality rates and have the potential for major public health impact; might cause public panic and social disruption; and require special action for public health preparedness. These include: • Anthrax (Bacillus anthracis) • Smallpox (variola major) • Botulism (Clostridium botulinum • Tularemia (Franciscella tularensis) toxin) • Viral Hemorrhagic Fevers (filoviruses, • Plague (Yersinia pestis) arenaviruses) Of second highest priority are category B agents which are organisms that are moderately easy to disseminate; that result in moderate morbidity rates and low mortality rates; and that require enhanced diagnostic capacity and disease surveillance. • Brucellosis (Brucella species)* • Epsilon toxin of Clostridium perfringens • Food safety threats (Salmonella species, Escherichia coli O157:H7, Shigella) • Glanders (Burkholderia
    [Show full text]
  • Health Advisory: Typhoid Fever in Ramsey County
    Health Advisory: Typhoid Fever in Ramsey County Minnesota Department of Health Tue Jun 18 13:00 CDT 2019 Action Steps Local and tribal health departments: Please forward to hospitals, clinics, emergency departments, urgent care centers, and convenience clinics in St. Paul-Ramsey county only. Hospitals and clinics: Please distribute to urgent care and primary care providers, pediatricians, infectious disease specialists, gastroenterologists, emergency medicine providers. Health care providers: • Consider enteric fever (e.g., typhoid fever) among patients presenting with unexplained fevers, especially persistent fevers lasting >3 days or fevers in combination with gastrointestinal symptoms (abdominal pain, constipation, or diarrhea) even in the absence of recent travel to an endemic area of the world. • Obtain blood cultures if enteric fever is suspected and consider cultures of other specimens. • Report cases of probable or confirmed enteric fever within 24 hours to MDH at 651-201-5414 or 1-877-676-5414 and call MDH for questions about testing for enteric fever. You can contact Dave Boxrud (651-201-5257, [email protected]) or [email protected] for testing questions Background On June 17, the Minnesota Department of Health (MDH) identified an outbreak of enteric fever caused by Salmonella enterica serotype Typhi in Ramsey County. Two patients have culture-confirmed infections and a third patient had symptoms compatible with enteric fever. Consumption of foods served at a local event is a suspected source of this outbreak. The patients’ ages range from 14 to 18 years and illness onset dates range from May 30 to June 1. Enteric fever is a bacteremic illness caused by ingestion of Salmonella Typhi (typhoid fever) or Salmonella serotype Paratyphi (paratyphoid fever) and is transmitted through a fecal-oral route.
    [Show full text]
  • Early History of Infectious Disease 
    © Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.
    [Show full text]
  • CDFA List of Reportable Conditions for Animals and Animal Products
    January 2021 ANIMAL HEALTH BRANCH LIST OF REPORTABLE CONDITIONS FOR ANIMALS AND ANIMAL PRODUCTS* *Pursuant to Section 9101 of the California Food and Agricultural Code, Title 3 California Code of Regulations § 797 and Title 9 Code of Federal Regulations Section 161.4(f) WHO MUST REPORT: Any licensed veterinarian, any person operating a diagnostic laboratory, or any person who has been informed, recognizes or should recognize by virtue of education, experience, or occupation, that any animal or animal product is or may be affected by, or has been exposed to, or may be transmitting or carrying any of the following conditions, must report that information. WHAT TO REPORT: Immediately report any animal disease not known to exist in the United States, any event with increased mortality and/or morbidity of unknown cause or source and any toxicology condition likely to contaminate animals or animal products (meat, milk or eggs). CALL IF YOU SEE: high morbidity or mortality, vesicles, CNS signs, uncommon ticks, hemorrhagic septicemias, unusual larvae in wounds, unusual or unexplained illness. Report any emergency, regulatory, or monitored condition within the provided time frame. Some diseases are listed under the major species of concern; if you see compatible signs for such conditions in another species, please report! EMERGENCY CONDITIONS REGULATORY CONDITIONS MONITORED CONDITIONS Report within 24 Hours of Discovery Report within Two Days of Discovery Report within 30 Days of Discovery MULTIPLE SPECIES MULTIPLE SPECIES MULTIPLE SPECIES • Brucellosis (B. melitensis, B. abortus, B. suis)1 • Bluetongue General, non-specific conditions: Unexplained high • Pseudorabies (Aujeszky’s disease) • Echinococcosis/hydatidosis (Echinococcus species) mortality or diseased animals; livestock exposed to toxic • Tuberculosis (Mycobacterium bovis)1 • Epizootic hemorrhagic disease substances.
    [Show full text]